Cyclic nucleotide phosphodiesterase 7B mRNA: An unfavorable characteristic in chronic lymphocytic leukemia

International Journal of Cancer

Volumn 129, Issue 5, 2011, Pages 1162-1169

  Zhang, Lingzhi ^a   Murray, Fiona ^a,b   Rassenti, Laura Z ^b,c   Pu, Minya ^a   Kelly, Colleen ^a   Kanter, Joan R ^a   Greaves, Andrew ^c   Messer, Karen ^a,c   Kipps, Thomas J ^b,c   Insel, Paul A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

chronic lymphocytic leukemia; cyclic nucleotide phosphodiesterase 7B; prognostic factor; quantitative reverse transcriptase polymerase chain reaction (QPCR)

Indexed keywords

BETA 2 MICROGLOBULIN; CD38 ANTIGEN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 7B; IMMUNOGLOBULIN HEAVY CHAIN; MESSENGER RNA; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ADULT; AGED; CASE-CONTROL STUDIES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 7; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TIME FACTORS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 79959745902     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25785     Document Type: Article

References (38)

1. Ghia P, Ferreri AM, Galigaris-Cappio F,. Chronic lymphocytic leukemia. Crit Rev Oncol Hematol 2007; 64: 234-46. (Pubitemid 350026781)
2. Udristioiu A, Florescu C, Radu-Popescu MA, Cojocaru M,. High concentrations of anaerobic adenosine-triphosphate may impair apoptosis in malignant B cells from patients with chronic lymphocytic leukemia. Lab Med 2010; 41: 203-8.
3. Chen J, McMillan NA,. Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia. Cancer Biol Ther 2008; 7: 174-9. (Pubitemid 351590419)
4. Butler T, Gribben JG,. Biologic and clinical significance of molecular profiling in chronic lymphocytic leukemia. Blood Rev 2010; 24: 135-41.
5. Scielzo C, Ten Hacken E, Bertilaccio MT, Muzio M, Calissano C, Ghia P, Caligaris-Cappio F,. How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection. Leuk Lymphoma 2010; 51: 1371-4.
6. Bertilaccio MT, Scielzo C, Muzio M, Caligaris-Cappio F,. An overview of chronic lymphocytic leukaemia biology. Best Pract Res Clin Haematol 2010; 23: 21-32.
7. Meyers JA, Su DW, Lerner A,. Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors. J Immunol 2009; 182: 5400-11.
8. Zhang L, Insel PA,. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem 2004; 279: 20858-65. (Pubitemid 38656482)
9. Lerner A, Epstein PM,. Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. Biochem J 2006; 393: 21-41. (Pubitemid 43049299)
10. Monahan TM, Marchand NW, Fritz RR, Abell CW,. Cyclic adenosine 3′:5′-monophosphate levels and activities of related enzymes in normal and leukemic lymphocytes. Cancer Res 1975; 35: 2540-7.
11. Carpentieri U, Monahan TM, Gustavson LP,. Observations on the level of cyclic nucleotides in three population of human lymphocytes in culture. J Cyclic Nucleotide Res 1980; 6: 253-9. (Pubitemid 11154339)
12. Bender AT, Beavo JA,. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58: 488-520. (Pubitemid 44394910)
13. Lugnier C,. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 2006; 109: 366-98. (Pubitemid 43132818)
14. Zhang L, Murray F, Zahno A, Kanter JR, Chou D, Suda R, Fenlon M, Rassenti L, Cottam H, Kipps TJ, Insel PA,. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2008; 105: 19532-7.
15. Vroblova V, Smolej L, Vrbacky F, Jankovicova K, Hrudkova M, Maly J, Krejsek J,. Biological prognostic markers in chronic lymphocytic leukemia. Acta Med (Hradec Kralove) 2009; 52: 3-8.
16. Mehes G,. Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia. Pathol Oncol Res 2005; 11: 205-10. (Pubitemid 43266922)
17. Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG,. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023-9. (Pubitemid 34525567)
18. Matrai Z,. CD38 as a prognostic marker in CLL. Hematology 2005; 10: 39-46. (Pubitemid 41093587)
19. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG,. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105-11. (Pubitemid 38068326)
20. Montserrat E,. New prognostic markers in CLL. Hematology Am Soc Hematol Educ Program 2006: 279-84.
21. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ,. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446-56.
22. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893-901. (Pubitemid 39096916)
23. Rassenti LZ, Jain S, Keating MJ, Wierda WG, Grever MR, Byrd JC, Kay NE, Brown JR, Gribben JG, Neuberg DS, He F, Greaves AW, et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 2008; 112: 1923-30.
24. Kay NE, Hamblin TJ, Jelinek DF, Dewald GW, Byrd JC, Farag S, Lucas M, Lin T,. Chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2002: 193-213.
25. Tobin G, Thunberg U, Johnson A, Eriksson I, Soderberg O, Karlsson K, Merup M, Juliusson G, Vilpo J, Enblad G, Sundstrom C, Roos G, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003; 101: 4952-7. (Pubitemid 36857759)
26. Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, Cortes J, Thomas D, Garcia-Manero G, Koller C, Beran M, Giles F, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 2007; 109: 4679-85. (Pubitemid 46827758)
27. Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, et al. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. J Clin Oncol 2007; 25: 4648-56. (Pubitemid 350041550)
28. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR,. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-7. (Pubitemid 26189840)
29. Xu W, Li JY, Miao KR, Cao X, Liu Q, Fan L, Qiao C, Wu YJ,. The negative prognostic significance of positive direct antiglobulin test in Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma 2009; 50: 1482-7.
30. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, Volinia S, Ferracin M, Palatini J, Balatti V, Alder H, Negrini M, et al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009; 114: 3872-9.
31. Kharfan-Dabaja MA, Chavez JC, Khorfan KA, Pinilla-Ibarz J,. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia. Cancer 2008; 113: 897-906.
32. Van Bockstaele F, Verhasselt B, Philippe J,. Prognostic markers in chronic lymphocytic leukemia: a comprehensive review. Blood Rev 2009; 23: 25-47.
33. Adinolfi E, Melchiorri L, Falzoni S, Chiozzi P, Morelli A, Tieghi A, Cuneo A, Castoldi G, Di Virgilio F, Baricordi OR,. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 2002; 99: 706-8. (Pubitemid 34533113)
34. Bingham J, Sudarsanam S, Srinivasan S,. Profiling human phosphodiesterase genes and splice isoforms. Biochem Biophys Res Commun 2006; 350: 25-32. (Pubitemid 44466570)
35. Stamatopoulos B, Meuleman N, Haibe-Kains B, Duvillier H, Massy M, Martiat P, Bron D, Lagneaux L,. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin Chem 2007; 53: 1757-66. (Pubitemid 47509668)
36. Noordhoek GT, Weel JF, Poelstra E, Hooghiemstra M, Brandenburg AH,. Clinical validation of a new real-time PCR assay for detection of enteroviruses and parechoviruses, and implications for diagnostic procedures. J Clin Virol 2008; 41: 75-80. (Pubitemid 351179446)
37. Takahashi T, Tamura M, Asami Y, Kitamura E, Saito K, Suzuki T, Takahashi SN, Matsumoto K, Sawada S, Yokoyama E, Takasu T,. Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis. J Clin Microbiol 2008; 46: 1698-707. (Pubitemid 351657217)
38. Bustin SA, Mueller R,. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci (Lond) 2005; 109: 365-79. (Pubitemid 41445244)